Select your preferred options and see the best price It looks like you missed filling in questions from the last consultation.Click Here to submit your response
Guerra C, Morris D, Sipin A, et al
Provider-prescribed GLP-1s: Routed through Ros pharmacy network with clinician oversight
Requiring companies to jump over bespoke New Zealand hurdles to access the New Zealand market, when theyve already proven themselves fit by jumping more rigorous hurdles overseas, just puts Kiwis at the back of the queue With these approvals in hand, and the drugs obvious safety attested to by its widespread use abroad, you might have expected Medsafe could simply have said, Yes please when Novo Nordisk finally filed for New Zealand approval
The glycosylation pattern the specific arrangement of sugar chains attached to the protein directly affects the drugs efficacy, immunogenicity, and safety profile, and it varies batch-to-batch within the same manufacturers own process